Publications by authors named "Uwe Martens"

Claim this Profile
S
Solving Riddles Through Sequencing (SIRIUS): unlocking hematologic diagnoses by whole genome and transcriptome sequencing.
Marietta Truger, Manja Meggendorfer, Wencke Walter, Stephan Hutter, Winfried Alsdorf, Uwe M Martens

Leukemia· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-term disease control of monomorphic epitheliotrophic intestinal T-cell lymphoma (MEITL) with CNS involvement in a caucasian patient by allogeneic hematopoietic cell transplantation.
Markus Lindauer, Florian Reissfelder, Ute Hegenbart, Thomas Luft, Uwe M Martens

Bone Marrow Transplant· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prospective systematic classification of causes of death in the course of multiple myeloma.
Jia Xiang Jin, Britta Besemer, Büsranur Yilmaz, Mathias Hänel, Roland Fenk, Uwe M Martens

Blood Cancer J· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Head-to-head comparison of TKI and CPI first-line treatment strategies in advanced renal cell carcinoma-Real-world data from the German research platform CARAT.
Peter J Goebell, Martin Bögemann, Arnd Nusch, Viktor Grünwald, Lothar Müller, Uwe M Martens

Int J Cancer· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
W
Whole Exome Sequencing on FHIR: Towards Adoption in Clinical Practice for Precision Oncology Pipelines.
Sara Nuhic, Patrick Werner, Daniel Kazdal, Michael Menzel, Albrecht Stenzinger, Uwe M Martens

Stud Health Technol Inform· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Response-guided first-line therapy and treatment of relapse in aggressive lymphoma: 10-year follow-up of the PETAL trial.
Ulrich Dührsen, Andreas Bockisch, Bernd Hertenstein, Imke E Karsten, Frank Kroschinsky, Uwe M Martens

Blood Neoplasia· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A real-world observation of patients with glioblastoma treated with a personalized peptide vaccine.
Pauline Latzer, Henning Zelba, Florian Battke, Annekathrin Reinhardt, Borong Shao, Uwe M Martens

Nat Commun· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Report from Health Professionals and Cancer Patients: Experiences and Wishes from Clinical Practice About the Integration of Quality of Life with a Health App.
Chantal N L Beutter, Stephanie Berger, Uwe M Martens, Christian Fegeler

Stud Health Technol Inform· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CD8 CD28 regulatory T cells after induction therapy predict progression-free survival in myeloma patients: results from the GMMG-HD6 multicenter phase III study.
Katharina Kriegsmann, Gigi Nu Hoang Quy Ton, Mohamed H S Awwad, Axel Benner, Uta Bertsch, Uwe M Martens

Leukemia· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Elotuzumab, lenalidomide, bortezomib, dexamethasone, and autologous haematopoietic stem-cell transplantation for newly diagnosed multiple myeloma (GMMG-HD6): results from a randomised, phase 3 trial.
Elias K Mai, Hartmut Goldschmid, Kaya Miah, Uta Bertsch, Britta Besemer, Uwe M Martens

Lancet Haematol· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
User-Centered Development of a Mobile App to Assess the Quality of Life of Patients With Cancer: Iterative Investigation and Usability Testing.
Chantal N L Beutter, Katharina Zeller, Uwe M Martens, Bettina Pfleiderer, Christian Fegeler

JMIR Cancer· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Intensive chemotherapy with or without gemtuzumab ozogamicin in patients with NPM1-mutated acute myeloid leukaemia (AMLSG 09-09): a randomised, open-label, multicentre, phase 3 trial.
Hartmut Döhner, Daniela Weber, Julia Krzykalla, Walter Fiedler, Michael W M Kühn, Uwe M Martens

Lancet Haematol· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The INFINITY study protocol: a retrospective cohort study on decision making and clinical impact of biomarker-driven precision oncology in routine clinical practice.
Uwe M Martens, Jan Schröder, Fee Bengsch, Ludger Sellmann, Sabine Busies

BMC Cancer· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Novel causative variants of VEXAS in UBA1 detected through whole genome transcriptome sequencing in a large cohort of hematological malignancies.
Maki Sakuma, Piers Blombery, Manja Meggendorfer, Claudia Haferlach, Markus Lindauer, Uwe M Martens

Leukemia· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Assessing Quality of Life Using FHIR - How to Combine Patient Reported Outcome with Patient Generated Data for Better Compliance.
Chantal N L Beutter, Patrick Werner, Stefan Sigle, Uwe Marc Martens, Christian Fegeler

Stud Health Technol Inform· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cure of intravascular NK/T-cell lymphoma of the central nervous system by allogeneic hematopoietic cell transplantation.
Julia Meissner, Michael Schmitt, Mindaugas Andrulis, Leonille Schweizer, Sascha Dietrich, Uwe M Martens

Bone Marrow Transplant· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Liquid profiling of circulating tumor DNA in colorectal cancer: steps needed to achieve its full clinical value as standard care.
Maren Hedtke, Rodrigo Pessoa Rejas, Matthias F Froelich, Volker Ast, Angelika Duda, Uwe M Martens

Mol Oncol· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Oral azacitidine preserves favorable level of fatigue and health-related quality of life for patients with acute myeloid leukemia in remission: results from the phase 3, placebo-controlled QUAZAR AML-001 trial.
Gail J Roboz, Hartmut Döhner, Christopher Pocock, Herve Dombret, Farhad Ravandi, Uwe M Martens

Haematologica· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comorbidities, Rather Than Older Age, Are Strongly Associated With Higher Utilization of Healthcare in Colorectal Cancer Survivors.
Melissa S Y Thong, Daniel Boakye, Lina Jansen, Uwe M Martens, Jenny Chang-Claude

J Natl Compr Canc Netw· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Advantages and Challenges of Using ctDNA NGS to Assess the Presence of Minimal Residual Disease (MRD) in Solid Tumors.
Lionel Larribère, Uwe M Martens

Cancers (Basel)· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Assessment of SARS-CoV-2 Infection among Healthcare Workers of a German COVID-19 Treatment Center.
Lionel Larribère, Jelizaveta Gordejeva, Lisa Kuhnhenn, Maximilian Kurscheidt, Monika Pobiruchin, Uwe M Martens

Int J Environ Res Public Health· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Neoadjuvant nivolumab for patients with resectable HPV-positive and HPV-negative squamous cell carcinomas of the head and neck in the CheckMate 358 trial.
Robert L Ferris, William C Spanos, Rom Leidner, Anthony Gonçalves, Uwe M Martens

J Immunother Cancer· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Q
Quality of Life as an Indicator for Care Delivery in Clinical Oncology Using FHIR.
Chantal N L Beutter, Jan Ross, Patrick Werner, Dilyana Vladimirova, Uwe M Martens

Stud Health Technol Inform· May 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Uptake Rates of Novel Therapies and Survival Among Privately Insured Versus Publicly Insured Patients With Colorectal Cancer in Germany.
Lina Jansen, Daniel Boakye, Elizabeth Alwers, Prudence R Carr, Christoph Reissfelder, Uwe M Martens

J Natl Compr Canc Netw· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Nab-paclitaxel plus gemcitabine versus nab-paclitaxel plus gemcitabine followed by FOLFIRINOX induction chemotherapy in locally advanced pancreatic cancer (NEOLAP-AIO-PAK-0113): a multicentre, randomised, phase 2 trial.
Volker Kunzmann, Jens T Siveke, Hana Algül, Eray Goekkurt, Gabriele Siegler, Uwe Martens

Lancet Gastroenterol Hepatol· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis